Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, September 2, 2019

Office of Technology Development presents a third opportunity to engage with industry

(for more information go to, or email for specific submission details):

Almirall is looking to sponsor academic research for target identification, validation, and/or to advance

pre-clinical therapeutic opportunities into clinical settings for “novel targets, pathways, or therapeutic

candidates relating to chronic immune-inflammatory disease” (expiration 9/30/19).  Funding up to $250K

per project to be awarded by Almirall in November 2019.



Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS 

The abstract submission deadline for the HHDC 2019 Research Symposium is Friday, October 4th.

Abstracts must be received by 5 p.m. HHDC 2019 Research Symposium will be held on Friday, November

15, 2019 at the Samis Education Center in Children’s Hospital in Oklahoma City. The Symposium will 

consist of selected oral presentations, a poster session, and Symposia talks by P. Darrell Neufer, PhD,

Professor, East Carolina University, Matthew Rodeheffer PhD, Associate Professor, Yale University and

Scott Summers, PhD, Professor and Chair, The University of Utah.  For abstract submission guidelines

and to RSVP for this free event, please go to:  

Please contact with any questions for this event.



OUHSC researchers, you may find this press release of interest:

The release describes the federal charges filed this week against a faculty researcher at the University of Kansas. 

The researcher neglected to disclose his appointments at other institutions on his federal grant applications, as required

by the granting agencies, and to the university, as required by the KU conflicts of interest policy. 

Disclosures of  potential conflicts of interest, such as support from or appointments at other institutions, are required by

federal funding agencies (see, for example, and

by OU’s Conflicts of Interest policy.  The linked documents are good reminders to all researchers who receive federal

funds to ensure their disclosures of potential conflicts of interest are complete and accurate for each grant submission

and renewal.  I strongly encourage you to review the grant applications you have submitted for your current grants and

ensure you have fully disclosed any conflicts, including appointments at other institutions – both U.S. and foreign – to

the granting agency and to the University.  If you have questions about reporting conflicts to the University, please

contact Martha Ogilvie at For assistance with grants, please contact your Sponsored

Program Administrator in the Office of Research Administration at



IMPORTANT NIH INFORMATION:  ORCID Number – an ORCID Number is required of all Individuals Supported

by Research Training, Fellowship, Research Education, and Career Development Awards Beginning in FY 2020.  This

requirement will go into effect October 1, 2020. For the specific Notice and instructions on how to get your assigned

ORCID Number please go to:



The University of Oklahoma Center on Native Health Center of Biomedical Research Excellence

(COBRE) on the Norman campus is requesting preproposals to advance inquiry into the social and behavioral

determinants of the health of American Indian people in Oklahoma. Interested candidates should submit a one-page

overview (including specific aims) of their proposed research as a PDF file to Paul Spicer ( no

later than September 15, 2019. Project budgets generally will not exceed $150,000 in direct costs for each year. 

For additional information refer to the attached document. Call for Proposals 190821.docx?ver=2019-08-26-082925-747


Save the Date – ORA Noon Conference

Navigating the ORA Proposal Submission Process

Speaker(s):      Caitlin Novotny, MBA, CRA, Sponsored Programs Administrator II, Office of Research    Administration

Offered:             September 25, 2019  LIB-299 12-1pm

Overview:          This session will cover the basics of proposal preparation and map out the process of submission

through the Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for

during the pre-award review, such as budget considerations, eligibility, and compliance with applicable rules and policies.

We will also cover topics related to proposal submission, such as grant routing forms and the systems used to submit

federal grants. The overall goal of this presentation is to provide a basic understanding of and advice on proposal

preparation and submission



National Cancer Institute Predoctoral to Post-Doctoral Fellow Transition Award (F99/K00)

OUHSC can nominate one graduate student in their 3rd or 4th year since beginning graduate school who is

working towards their PhD degree to apply for an F99/K00 award from the NCI

(  Note: Dual-degree, or professional doctorate/

clinical degree students are not eligible.

  1. Purpose:  The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to

encourage and retain outstanding graduate students recognized by their institutions for their high potential

and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the

transition of talented graduate students into successful cancer research postdoctoral appointments, and

provide opportunities for career development activities relevant to their long-term career goals of becoming

independent cancer researchers. Final F99/K00 application due date at NIH is December 4th.

  1. Eligibility:  3rd or 4th year graduate student working on a specific cancer-related Ph.D. dissertation project

that wants to transition in the next 1-2 years to a postdoctoral fellowship research in cancer research.

  1. Submitting a pre-proposal:  A pre-proposal must be submitted to the Graduate College by September 6, 2019.

Pre-proposals must include:

  1. Specific Aims Page: there are 2 required Specific Aims as follow:
  1. Aim 1: The Dissertation Research Project
  2. Aim 2: The Postdoctoral Research Direction
  1. Letter of support from F99 sponsor(s)
  2. Full CV of applicant including academic record and prior research experience
  3. NIH Biosketch of sponsor(s)
  1. Submit the pre-proposal as a single file in PDF format to: in the Graduate College
  2. Pre-proposals will be reviewed by a panel of expert cancer researchers and educators.
  3. Questions: contact or



DEADLINE UPDATE: IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to support

collaborative research activities between OUHSC researchers and OU-Norman researchers in the area of biomedical engineering

Deadline September 6, 2019 – please see guidelines and face page attached page_final.pdf?ver=2019-07-01-074315-193




NIH Announces New Centralized Notifications for Unfunded Applications (NOT-OD-19-133)


Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding

Proposed Human Fetal Tissue Research (NOT-OD-19-137)


Notice of Informational Webinar on the NIH Maximizing Opportunities for Scientific and Academic Independent Careers

(MOSAIC) Program Funding Opportunity Announcements (UE5 and K99/R00)


Request for Information (RFI): Strategies to Support Acquisition and Use of Biospecimens for Research on Sepsis in

Humans (NOT-GM-19-057)


Notice of NIAAA's Participation in PAR-19-162 "Accelerating the Pace of Child Health Research Using Existing Data

from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)” (NOT-AA-19-023)


Notice of NIAAA's Participation in PAR-19-163 "Accelerating the Pace of Child Health Research Using Existing Data

from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)" (NOT-AA-19-024)


Notice to Extend the Expiration Date for PAR-18-644 "Advanced-Stage Development and Utilization of Research

Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)" (NOT-AG-19-038)


Notice to Extend the Expiration Date for PAR-18-645 "Research Infrastructure Development for Interdisciplinary Aging

Studies (R21/R33 - Clinical Trial Optional)" (NOT-AG-19-039)


Notice of FY2020 Cohort Dates for PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational

Research (Admin Supp Clinical Trial Not Allowed) (NOT-CA-19-067)


Notice to Extend PAR-18-727, Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary

Exposure (R01 Clinical Trial Optional) (NOT-DK-19-018)


Notice of Increased Budget Limits and NINDS Participation in PAS-19-317 "Advancing Research on Alzheimer's Disease

(AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" (NOT-NS-20-001)


Notice to Extend the Expiration Date for PA-18-141 "Mechanisms, Models, Measurement, & Management in Pain Research

(R01 Clinical Trial Optional)" (NOT-NS-20-003)


Notice to Extend the Expiration Date for PA-18-159 "Mechanisms, Models, Measurement, & Management in Pain Research

(R21 Clinical Trial Optional)" (NOT-NS-20-004)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients

(R21 Clinical Trial Not Allowed) (PAR-19-351) – Deadline October 16,2019 and February 16, 2020